PL351546A1 - 1,5−benzodiazepine derivatives as cck−a receptor agonists - Google Patents

1,5−benzodiazepine derivatives as cck−a receptor agonists

Info

Publication number
PL351546A1
PL351546A1 PL00351546A PL35154600A PL351546A1 PL 351546 A1 PL351546 A1 PL 351546A1 PL 00351546 A PL00351546 A PL 00351546A PL 35154600 A PL35154600 A PL 35154600A PL 351546 A1 PL351546 A1 PL 351546A1
Authority
PL
Poland
Prior art keywords
cck
receptor agonists
benzodiazepine derivatives
benzodiazepine
derivatives
Prior art date
Application number
PL00351546A
Inventor
David Colclough
Anne Hodgson
Jerzy Ryszard Szewczyk
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9910366.5A external-priority patent/GB9910366D0/en
Priority claimed from GBGB0008179.4A external-priority patent/GB0008179D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of PL351546A1 publication Critical patent/PL351546A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/12—1,5-Benzodiazepines; Hydrogenated 1,5-benzodiazepines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL00351546A 1999-05-06 2000-05-04 1,5−benzodiazepine derivatives as cck−a receptor agonists PL351546A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9910366.5A GB9910366D0 (en) 1999-05-06 1999-05-06 1,5-Benzodiazepine Derivatives
GBGB0008179.4A GB0008179D0 (en) 2000-04-05 2000-04-05 Chemical process

Publications (1)

Publication Number Publication Date
PL351546A1 true PL351546A1 (en) 2003-05-05

Family

ID=26244033

Family Applications (1)

Application Number Title Priority Date Filing Date
PL00351546A PL351546A1 (en) 1999-05-06 2000-05-04 1,5−benzodiazepine derivatives as cck−a receptor agonists

Country Status (21)

Country Link
EP (1) EP1212305A2 (en)
JP (1) JP2002544200A (en)
KR (1) KR20020012567A (en)
CN (1) CN1161345C (en)
AR (1) AR022044A1 (en)
AU (1) AU4754800A (en)
BR (1) BR0010338A (en)
CA (1) CA2370801A1 (en)
CO (1) CO5170461A1 (en)
CZ (1) CZ20013988A3 (en)
HK (1) HK1046138A1 (en)
HU (1) HUP0201181A3 (en)
IL (1) IL146124A0 (en)
MX (1) MXPA01011267A (en)
MY (1) MY138319A (en)
NO (1) NO20015397L (en)
NZ (1) NZ515048A (en)
PE (1) PE20010110A1 (en)
PL (1) PL351546A1 (en)
TR (1) TR200103169T2 (en)
WO (1) WO2000068209A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005035793A2 (en) * 2003-10-09 2005-04-21 Decode Genetics Ehf. Cckar markers and haplotypes associated with extreme weight conditions
JP4069159B2 (en) 2004-05-25 2008-04-02 ファイザー・プロダクツ・インク Tetraazabenzo [e] azulene derivatives and analogs thereof
KR20220150270A (en) 2019-10-07 2022-11-10 칼리오페, 인크. GPR119 agonists

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9307833D0 (en) * 1993-04-15 1993-06-02 Glaxo Inc Modulators of cholecystokinin and gastrin

Also Published As

Publication number Publication date
NZ515048A (en) 2004-01-30
TR200103169T2 (en) 2002-04-22
AU4754800A (en) 2000-11-21
CN1161345C (en) 2004-08-11
IL146124A0 (en) 2002-07-25
NO20015397D0 (en) 2001-11-05
WO2000068209A2 (en) 2000-11-16
KR20020012567A (en) 2002-02-16
MY138319A (en) 2009-05-29
CN1362949A (en) 2002-08-07
EP1212305A2 (en) 2002-06-12
CO5170461A1 (en) 2002-06-27
MXPA01011267A (en) 2002-05-06
JP2002544200A (en) 2002-12-24
HUP0201181A3 (en) 2003-10-28
BR0010338A (en) 2002-02-13
CA2370801A1 (en) 2000-11-16
CZ20013988A3 (en) 2002-02-13
NO20015397L (en) 2001-11-05
HK1046138A1 (en) 2002-12-27
PE20010110A1 (en) 2001-03-05
AR022044A1 (en) 2002-09-04
WO2000068209A3 (en) 2001-03-01
HUP0201181A2 (en) 2002-12-28

Similar Documents

Publication Publication Date Title
PL346648A1 (en) 4,4-biarylpiperidine derivatives with opioid receptor activity
HK1051037A1 (en) Benzodiazepine derivatives.
HK1051038A1 (en) Benzodiazepine derivatives.
ZA200003927B (en) 1,2,4,5-tetrahydro-benzo[d]jazepines.
ZA985678B (en) 1-amino-alkylcyclohexane NMDA receptor antagonists.
PL351611A1 (en) 4,5,6,7-tetrahydroindazole derivatives as antitumor agents
AU4006800A (en) 1,2-dithiolane derivatives
EP1066262A4 (en) Imidazolone anorectic agents: i. acyclic derivatives
PL356990A1 (en) Isoxazolecarboxamide derivatives as alpha1-adrenergic receptor antagonists
IL149584A0 (en) New phenalkyloxy-phenyl derivatives
AU3819200A (en) 2,4-diamino-pyrimidine derivatives
IL146151A0 (en) Human-g-protein receptor
IL136500A0 (en) 1,4-diazacycloheptane derivatives
PL351546A1 (en) 1,5−benzodiazepine derivatives as cck−a receptor agonists
AU1100300A (en) Piperidyloxadiazoles as dopamine receptor antagonists
EP1189944A4 (en) Axor16, a g protein coupled receptor
AU2574801A (en) Selective iGLUR5 receptor antagonists
HUP9902291A2 (en) New 2,3-benzodiazepine derivatives
AU5912300A (en) 16405 receptor, a g-protein coupled receptor
GB2350361B (en) 3,4,5-tricyanophenyl derivatives
ZA200201873B (en) Fluorene derivatives.
AU2734600A (en) 17723 receptor, a g-protein coupled receptor
GB9910366D0 (en) 1,5-Benzodiazepine Derivatives
AU2512800A (en) Alpha1-adrenergic receptor antagonists
ZA200203703B (en) New Phenalkyloxy-phenyl derivatives.

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)